CoChat

Residual Pituitary Function after Brain Injury-Induced Hypopituitarism: A Prospective 12-Month Study

Aimaretti, Gianluca, Ambrosio, Maria Rosaria, Di Somma, Carolina, Gasperi, Maurizio, Cannavò, Salvatore, Scaroni, Carla, Fusco, Alessandra, Del Monte, Patrizia, De Menis, Ernesto, Faustini-Fustini, Marco, Grimaldi, Franco, Logoluso, Francesco, Razzore, Paola, Rovere, Silvia, Benvenga, Salvatore, degli Uberti, Ettore Ciro, De Marinis, Laura, Lombardi, Gaetano, Mantero, Franco, Martino, Enio, Giordano, Giulio, Ghigo, Ezio · 2005 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Context: Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are conditions at high risk for the development of hypopituitarism. Objective: The objective of the study was to clarify whether pituitary deficiencies and normal pituitary function recorded at 3 months would improve or worsen at 12 months after the brain injury. Design and Patients: Pituitary function was tested at 3 and 12 months in patients who had TBI (n = 70) or SAH (n = 32). Results: In TBI, the 3-month evaluation had shown hypopituitarism (H) in 32.8%. Panhypopituitarism (PH), multiple (MH), and isolated (IH) hypopituitarism had been demonstrated in 5.7, 5.7, and 21.4%, respectively. The retesting demonstrated some degree of H in 22.7%. PH, MH, and IH were present in 5.7, 4.2, and 12.8%, respectively. PH was always confirmed at 12 months, whereas MH and IH were confirmed in 25% only. In 5.5% of TBI with no deficit at 3 months, IH was recorded at retesting. In 13.3% of TBI with IH at 3 months, MH was demonstrated at 12-month retesting. In SAH, the 3-month evaluation had shown H in 46.8%. MH and IH had been demonstrated in 6.2 and 40.6%, respectively. The retesting demonstrated H in 37.5%. MH and IH were present in 6.2 and 31.3%, respectively. Although no MH was confirmed at 12 months, two patients with IH at 3 months showed MH at retesting; 30.7% of SAH with IH at 3 months displayed normal pituitary function at retesting. In SAH, normal pituitary function was always confirmed. In TBI and SAH, the most common deficit was always severe GH deficiency. Conclusion: There is high risk for H in TBI and SAH patients. Early diagnosis of PH is always confirmed in the long term. Pituitary function in brain-injured patients may improve over time but, although rarely, may also worsen. Thus, brain-injured patients must undergo neuroendocrine follow-up over time.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2005-0504

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

37 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 2

  1. Lissett, 1996, Hypopituitarism, In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: Saunders;, 145
  2. Faglia, 2001, Clinical aspects of the pituitary gland, In: Pinchera A, ed. Endocrinology and metabolism. London: McGraw-Hill International;, 73

Cited by

See all 370

Metadata

Authors
Aimaretti, G., Ambrosio, M. R., Di Somma, C., Gasperi, M., Cannavò, S., Scaroni, C., Fusco, A., Del Monte, P., De Menis, E., Faustini-Fustini, M., Grimaldi, F., Logoluso, F., Razzore, P., Rovere, S., Benvenga, S., degli Uberti, E. C., De Marinis, L., Lombardi, G., Mantero, F., Martino, E., Giordano, G., & Ghigo, E.
Affiliations
  • University of Turin (IT)
  • University of Ferrara (IT)
  • Departments of Molecular and Clinical Endocrinology and Oncology (C.D.S., G.L.), University of Naples Federico IIø, 80138 Naples, Italy;
  • University of Pisa (IT)
  • Department of Medicine and Pharmacology (S.C., S.B.), Section of Endocrinology, University of Messina, 98100 Messina, Italy;
  • University of Padua (IT)
  • Università Cattolica del Sacro Cuore (IT)
  • Division of Endocrinology (P.D.M.), Galliera Hospital, 16128 Genova, Italy;
  • Service of Endocrinology (E.D.M.), Treviso Hospital, 31100 Treviso, Italy;
  • Division of Endocrinology (M.F.-F.), Bellaria Hospital, 40139 Bologna, Italy;
  • Ospedale Santa Maria della Misericordia di Udine (IT)
  • University of Bari Aldo Moro (IT)
  • Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
  • University of Messina (IT)
  • Department of Biomedical Sciences and Advanced Therapies (M.R.A., E.C.d.U.), Section of Endocrinology, University of Ferrara, 44100 Ferrara, Italy;
  • Division of Endocrinology (A.F., L.D.M.), Catholic University, 00168 Rome, Italy;
  • University of Naples Federico II (IT)
  • Società Italiana di Endocrinologia (IT)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-11-01
Volume
90
Issue
11
Pages
6085-6092
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2109931368
Cited by
370
References
42
Citations by year
2026: 7 · 2025: 10 · 2024: 16 · 2023: 9 · 2022: 8 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 13 · 2017: 12 · 2016: 20 · 2015: 25 · 2014: 24 · 2013: 24 · 2012: 27
FWCI
15.96
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
traumatic brain injury, subarachnoid hemorrhage, hypopituitarism, pituitary function, panhypopituitarism, multiple pituitary hormone deficiency, growth hormone deficiency, pituitary function recovery, long-term outcomes
MeSH terms
Adult, Brain Injuries, Diabetes Insipidus, Female, Humans, Hypopituitarism, Male, Pituitary Gland, Prospective Studies, Subarachnoid Hemorrhage, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.